Status:
COMPLETED
Pilot Study on Proteomics of Erythrocyte Proteins in Patients With COPD Based on TMT Technology
Lead Sponsor:
Zhujiang Hospital
Conditions:
Protein; Disease
Eligibility:
All Genders
40-80 years
Brief Summary
Chronic obstructive pulmonary disease (COPD), a common and complex disease characterized by persistent airflow limitation, is a leading cause of mortality worldwide. COPD and its comorbidity are assoc...
Eligibility Criteria
Inclusion
- case group
- Age from 40 to 80 years old; gender is not limited.
- Stable COPD
- Sign the informed consent with the willingness of obeying the protocol. -
Exclusion
- Subjects with known other chronic respiratory diseases except for COPD (such as asthma, tuberculosis, bronchiectasis, interstitial lung disease, occupational lung diseases, sarcoidosis, lung cancer, et al);
- Subjects had been accepted lung lobectomy or transplantation;
- Subjects be ill with severe, or uncontrolled systemic diseases other than COPD (such as psychiatry diseases, chronic liver diseases, heart failure, auto-immunity diseases, chronic renal diseases, et al );
- Alcoholism, drug or solvents addition;
- Acute exacerbation COPD patients (AECOPD) -
- control group Inclusion criteria
- Age from 40 to 80 years old; gender is not limited.
- Sign the informed consent with the willingness of obeying the protocol. - Exclusion criteria
- <!-- -->
- Subjects with known other chronic respiratory diseases (such as COPD, asthma, tuberculosis, bronchiectasis, interstitial lung disease, occupational lung diseases, sarcoidosis, lung cancer, et al);
- Subjects had been accepted lung lobectomy or transplantation;
- Subjects be ill with severe, or uncontrolled systemic diseases other than COPD (such as psychiatry diseases, chronic liver diseases, heart failure, auto-immunity diseases, chronic renal diseases, et al );
- Alcoholism, drug or solvents addition;
Key Trial Info
Start Date :
July 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 15 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05376618
Start Date
July 15 2021
End Date
July 15 2022
Last Update
March 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhujiang Hospital,Southern Medical Universtiy
Guangzhou, Guangdong, China, 510282